This study is conducted in Africa, Asia, Europe, North America and South America. The purpose of the survey is to identify the key psychosocial issues affecting patients with haemophilia.
Study Type
OBSERVATIONAL
Enrollment
1,236
No treatment given. Participants are to complete a questionnarie in the study.
Novo Nordisk Investigational Site
Mississauga, Canada
Novo Nordisk Investigational Site
Madrid, Spain
Novo Nordisk Investigational Site
Crawley, United Kingdom
To quantify the extent of key psychosocial factors affecting patients with haemophilia in their daily lives
Time frame: After 6 weeks (recruitment and data collection)
To quantify how psychosocial factors are associated with treatment outcomes, compliance, health and general well-being
Time frame: After 6 weeks (recruitment and data collection)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.